Study for Efficacy and Safety Assessment of the Drug RADAMIN®VIRO for COVID-19 Postexposure Prophylaxis
Clinical trial NCT05722691 · COMPLETED
Trial details
- NCT number
- NCT05722691
- Sponsor
- Promomed, LLC
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-06-09
- Primary completion
- 2022-11-22
- Enrollment
- 800
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.